{"url_path":"/sec/ipsc/8-k/2026-06-12/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 ****Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-12","source_url":"https://www.sec.gov/Archives/edgar/data/1850119/0001104659-26-073429-index.html","accession_number":"0001104659-26-073429","cik":"0001850119","ticker":"IPSC","issuer_name":"Century Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1850119/0001104659-26-073429-index.html","primary_entity_key":"0001850119","primary_entity_name":"Century Therapeutics, Inc."},"word_count":189,"has_tables":true,"body_markdown":"**Item 5.03****Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.**\n\n \n\nAs further described under Item 5.07 of this Current Report on this\nForm 8-K, at the 2026 Annual Meeting of Stockholders (the “Annual Meeting”), and upon the recommendation of the Board\nof Directors (the “Board”), the stockholders of Century Therapeutics, Inc. (the “Company”) approved a Certificate\nof Amendment to the Company’s Second Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized\nshares of common stock, par value $0.0001 per share (“Common Stock”, and such amendment, the “Authorized Shares Amendment”).\nThe Authorized Shares Amendment was previously approved by the Board, subject to stockholder approval.\n\n \n\nThe Authorized Shares Amendment was filed with the Secretary of State\nof the State of Delaware on June 11, 2026. The Authorized Shares Amendment became effective on June 12, 2026.\n\n \n\nThe foregoing description of the Authorized Shares Amendment does not\npurport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which\nis filed as Exhibit 3.1 to this Form 8-K and incorporated herein by reference."}